Effect of octreotide, a somatostatin analogue, on release of inflammatory mediators from isolated guinea pig bladder

Journal of Urology

Volumn 158, Issue 1, 1997, Pages 258-264

  Bjorling, Dale E ^a   Saban, Marcia R ^a   Saban, Ricardo ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Bladder; Inflammation; Somatostatin

Indexed keywords

BRADYKININ; HISTAMINE; INDOMETACIN; LEUKOTRIENE B4; NEUROKININ A; NEUROPEPTIDE; OCTREOTIDE; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; SOMATOSTATIN DERIVATIVE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; FEMALE; GUINEA PIG; HISTAMINE RELEASE; INTRAMUSCULAR DRUG ADMINISTRATION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE;

EID: 0030940834     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199707000-00082     Document Type: Article

References (45)

1. Harris, A. G.: Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut, 35(Suppl. 3): S1, 1994.
2. van Hagan, P. M., Krenning, E. P., Kwekkeboom, D. J., Reubi, J. C., Anker-Lugtenburg, P. J., Lowenberg, B. and Lamberts, S. W. J.: Somatostatin and the immune and haematopoetic system: a review. Eur. J. Clin. Invest., 24: 9, 1994.
3. Gu, J., Blank, M. A., Huang, W. M., Islam, K. N., McGregor, G. P., Christofides, N., Allen, J. M., Bloom, S. R. and Polak, J. M.: Peptide-containing nerves in human urinary bladder. Urology, 24: 353, 1984.
4. Keast, J. R. and DeGroat, W. C.: Segmental distribution and peptide content of primary afferent neurons innervating the urogenital organs and colon of male rats. J. Comp. Neurol., 319: 615, 1992.
5. Ahluwalia, A., Maggi, C. A., Santicioloi, P., Lecci, A. and Giuliani, S.: Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br. J. Pharmacol., 111: 1017, 1994.
6. Bjorling, D. E., Saban, M. R. and Saban, R.: Neurogenic inflammation of guinea-pig bladder. Mediators Infl., 3: 189, 1994.
7. Giuliani, S., Santicioli, P., Lippe, I. T., Lecci, A. and Maggi, C. A.: Effect of bradykinin and tachykinin receptor antagonist on xylene-induced cystitis in rats. J. Urol., 150: 1014, 1993.
8. Maggi, C. A., Patacchini, R., Santicioli, P. and Giuliani, S.: Tachykinin antagonists and capsaicin-induced contractions of the rat isolated urinary bladder: evidence for tachykinin-mediated cotransmission. Br. J. Pharmacol., 103: 1535, 1991.
9. Maggi, C. A., Santicioli, P., Del-Bianco, E., Lecci, A. and Giuliani, S.: Evidence of the involvement of bradykinin in chemically-evoked cystitis in anaesthetized rats. Naunyn. Schmied. Arch. Pharmacol., 347: 432, 1993.
10. Hall, J. M.: Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther., 56: 131, 1992.
11. Diel, F., Bethge, N. and Opree, W.: Histamine secretion in leukocyte incubates of patients with allergic hyperreactivity induced by somatostatin-14 and somatostatin-28. Agents Actions, 13: 216, 1983.
12. Diel, F. and Usadel, K. H.: Somatostatin-induced histamine release in mast cell incubates from thymusaplastic nude rats. Agents Actions, 14: 506, 1984.
13. Theoharides, T. C. and Douglas, W. W.: Mast cell histamine secretion in response to somatostatin analogues: structural considerations. Eur. J. Pharmacol., 73: 131, 1981.
14. Pawlikowsky, M., Stepien, H., Kunert-Radek, J., Zelazowski, P. and Schally, A. V.: Immunomodulatory action of somatostatin. Ann. N. Y. Acad. Sci., 496: 233, 1987.
15. Betoin, F., Ardid, D., Herbet, A., Aumaitre, O., Kemeny, J. L., Duchene-Marullaz, P., Lavarenne, J. and Eschalier, A.: Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism. J. Pharmacol. Exp. Therap., 269: 7, 1994.
16. Karalis, K., Mastorakos, G., Chrousos, G. P. and Tolis, G.: Somatostatin analogues suppress the inflammatory reaction in vivo. J. Clin. Invest., 93: 2000, 1994.
17. Fioravanti, A., Govoni, M., La Montagna, G., Perpignano, G., Tirri, G., Trotta, F., Bogliolo, A., Ciocci, A., Mauceri, M. T. and Marcolongo, R.: Somatostatin 14 and joint inflammation: evidence for intraarticular efficacy of prolonged administration in rheumatoid arthritis. Drugs Under Exper. Clin. Res., 21: 97, 1995.
18. Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P. and Petcher, T. J.: SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci., 31: 1133, 1982.
19. Hunt, T. C., Campbell, A. M., Robinson, C. and Holgate, S. T.: Structural and secretory characteristics of bovine lung and skin mast cells: evidence for the existence of heterogeneity. Clin. Exp. Allerg., 21: 173, 1991.
20. Lowman, M. A., Benyon, R. C. and Church, M. K.: Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br. J. Pharmacol., 95: 121, 1988.
21. Miller, L. A., Cochrane, D. E., Carraway, R. E. and Feldberg, R. S.: Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor. Br. J. Pharmacol., 114: 1466, 1995.
22. Patella, V., de Crescenzo, G., Ciccarelli, A., Marino, I., Adt, M. and Marone, G.: Human heart mast cells: a definitive case of mast cell heterogeneity. Internat. Arch. Allerg. Immunol., 106: 386, 1995.
23. Undem, B. J., Adams, G. K., III and Buckner, C. K.: Influence of electrical field stimulation on antigen-induced contraction and mediator release in the guinea pig isolated superfused trachea and bronchus. J. Pharmacol. Exp. Ther., 249: 23, 1989.
24. Hogaboam, C. M., Bissonnette, E. Y., Chin, B. C., Befus, A. D. and Wallace, J. L.: Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology, 104: 122, 1993.
25. Ashby, B.: Prostaglandins and related autocoids. In: Human Pharmacology: Molecular to Clinical. Edited by T. M. Brody, J. Lamer, K. P. Minneman and H. C. Neu, St. Louis: Mosby, 2nd ed., chapt. 18, pp. 225-234, 1995.
26. Bjorling, D. E., Saban, M. R., Bruskewitz, R. C. and Saban, R.: Response of the isolated guinea pig bladder to exogenous and endogenous leukotrienes. J. Urol., 152: 1281, 1994.
27. Lee, J. G., Levin, R. M., Krasnopolsky, L., Wein, A. J. and Longhurst, P. A.: Effects of the peptide leukotriene receptor antagonist ICI 198,615 on the in vivo and in vitro changes in guinea pig bladder function which occur after sensitization with ovalbumin. J. Urol., 154: 1217, 1995.
28. Adcock, J. J., Garland, L. G., Moncada, S. and Salmon, J. A.: The mechanism of enhancement by fatty acid hydroperoxides of anaphylactic mediator release. Prostaglandins, 16: 179, 1978.
29. Sprague, R. S., Stephenson, A. H., Joshi, S. N. and Lonigro, A. J.: Effect of indomethacin on increases in leukotriene B4 and pulmonary edema in response to phorbol ester administration in dogs. Biochem. Pharmacol., 48: 1009, 1994.
30. Undem, B. J., Pickett, W. C. and Adams, G. K. III.: Antigen-induced sulfidopeptide leukotriene release from the guinea pig superfused trachea. Eur. J. Pharmacol., 142: 31, 1987.
31. Imai, T., Adachi, M., Idaira, K., Enomoto, T., Matsuura, T., Kimura, T., Gonogami, Y., Mita, S., Takahashi, T. and Tanaka, Y.: Effect of indomethacin on the release of chemical mediators from human peripheral leukocytes. Jap. J. Allerg., 42: 1585, 1993.
32. Karmeli, F., Eliakim, R., Okon, R. and Rachmilewitz, D.: Somatostatin effectively prevents ethanol- and NSAID-induced gastric mucosal damage in rats. Dig. Dis. Sci., 39: 617, 1994.
33. Mezei, Z., Geese, A. and Telegdy, G.: The effects of somatostatin on the arachidonate cascade of platelets. Prostaglandins, 36: 399, 1988.
34. Goetzel, E. J. and Payan, D. G.: Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. J. Immunol., 133: 3255, 1984.
35. Goetzel, E. J., Chernov-Rogan, T., Cooke, M. P., Renold, F. and Payan, D.: Endogenous somatostatin-like peptides of rat basophilic leukemia cells. J. Immunol., 135: 2707, 1985.
36. Goetzl, E. J., Chernov, T., Renold, F. and Payan, D. G.: Neuropeptide regulation of the expression of immediate hypersensitivity. J. Immunol., 135(Suppl. 2): 802s, 1985.
37. Ahmed, M. and Davison, O. W.: Severe cystitis associated with tiaprofenic acid. Br. Med. J., 303: 1376, 1991.
38. 2 in acute bacterial cystitis. J. Urol., 124: 455, 1980.
39. Saban, R., Christensen, M., Keith, I., Graziano, F. M., Undem, B. J., Aagaard, J., Bjorling, D. E. and Bruskewitz, R. C.: Experimental model for the study of bladder mast cell degranulation and smooth muscle contraction. Sem. Urol., 9: 88, 1991.
40. Pang, X., Marchand, J., Sant, G. R., Kream, A. M. and Theoharides, T. C.: Increased number of substance P positive fibres in interstitial cystitis. Br. J. Urol., 75: 744, 1995.
41. Tomaki, M., Ichinose, M., Miura, M., Hirayama, Y., Yanauchi, H., Nakajima, N. and Shirato, K.: Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am. J. Respir. Crit. Care Med., 151: 613, 1995.
42. Crofford, L. J., Sano, H., Karalis, K., Webster, E. L., Goldmuntz, E. A., Chrousos, G. P. and Wilder, R. L.: Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J. Clin. Invest., 90: 2555, 1992.
43. Lilly, C. M., Hall, A. E., Rodger, I. W., Kobzik, L., Haley, K. J. and Drazen, J. M.: Substance P-induced histamine release in tracheally perfused guinea pig lungs. J. Appl. Physiol., 78: 1234, 1995.
44. Lach, E., Trifilieff, A., Mousli, M., Landry, Y. and Gies, J. P.: Bradykinin-induced contraction of guinea pig lung in vitro. Naunyn-Schmied. Arch. Pharmacol., 350: 201, 1994.
45. Wallengren, J. and Hakanson, R.: Effects of capsaicin, bradykinin and prostaglandin E2 in the human skin. Br. J. Dermatol., 126: 111, 1992.